{"id":"9ac9b0c18b2e","type":"article","url":"https://hartvaat.nl/2021/02/09/2020-acc-consensus-anticoagulatie-en-antiplaatjestherapie-bij-af-of-vte/","title":"2020 ACC consensus: anticoagulatie en antiplaatjestherapie bij AF of VTE","title_en":"2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.","category":"atriumfibrilleren","category_label":"Atriumfibrilleren","professions":["apotheker","cardioloog"],"tags":["anticoagulantia","anticoagulatie-kwetsbare-ouderen"],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2020.09.011","source_url":"https://doi.org/10.1016/j.jacc.2020.09.011","authors":["Dharam J Kumbhani","Christopher P Cannon","Craig J Beavers","Deepak L Bhatt","Adam Cuker","Ty J Gluckman","Joseph E Marine","Roxana Mehran","Steven R Messe","Nimesh S Patel","Benjamin E Peterson","Kenneth Rosenfield","Sarah A Spinler","Vinod H Thourani"],"significance":8,"published":"2021-02-09","source_date":"2021-02-09","image":"","kennis":["https://hartvaat.nl/kennis/atriumfibrilleren/ritmecontrole-af/","https://hartvaat.nl/kennis/atriumfibrilleren/af-bij-ouderen/"],"congress":"","summary_en":"The 2020 ACC Expert Consensus provided a comprehensive decision pathway for managing antithrombotic therapy in patients with atrial fibrillation or venous thromboembolism who require antiplatelet agents, with practical algorithms for diverse clinical scenarios.","created":"2026-07-03T10:29:03Z","updated":"2026-07-03T13:28:11Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"ACC 2020 expert consensus decision pathway voor antistollings- en antiplaatjestherapie bij AF of VTE.","abstract_original":""}